Immunologic Effects of CCR5 Blockade in Graft-Versus-Host Disease Prophylaxis

被引：0
|
作者：
Moy, Ryan H. [1 ,2 ]
Huffman, Austin P. [2 ,3 ,4 ]
Richman, Lee P. [2 ]
Crisalli, Lisa [2 ]
Hoxie, James A. [2 ]
Vonderheide, Robert H. [2 ]
Porter, David L. [2 ]
Reshef, Ran [3 ,4 ]
机构：
[1] NewYork Presbyterian Hosp, Weill Cornell Med Coll, Dept Med, New York, NY USA
[2] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[3] Columbia Univ, Med Ctr, Dept Med, Div Hematol Oncol, New York, NY USA
[4] Columbia Univ, Med Ctr, Dept Med, Columbia Ctr Translat Immunol, New York, NY USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis
    Moy, Ryan H.
    Huffman, Austin P.
    Richman, Lee P.
    Crisalli, Lisa
    Wang, Ximi K.
    Hoxie, James A.
    Mick, Rosemarie
    Emerson, Stephen G.
    Zhang, Yi
    Vonderheide, Robert H.
    Porter, David L.
    Reshef, Ran
    BLOOD, 2017, 129 (07) : 906 - 916
  • [2] Pharmacodynamic Monitoring Predicts Outcomes of CCR5 Blockade as Graft-versus-Host Disease Prophylaxis
    Huffman, Austin P.
    Richman, Lee P.
    Crisalli, Lisa
    Ganetsky, Alex
    Porter, David L.
    Vonderheide, Robert H.
    Reshef, Ran
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : 594 - 599
  • [3] Extended CCR5 Blockade in Graft-Versus-Host Disease Prophylaxis - a Phase ll Study
    Reshef, Ran
    Mangan, James K.
    Luger, Selina M.
    Loren, Alison Wakoff
    Hexner, Elizabeth O.
    Frey, Noelle V.
    Stadtmauer, Edward A.
    Blauser, Robin E.
    Richman, Lee P.
    Huffman, Austin P.
    Ganetsky, Alex
    Acosta, Edward P.
    Hoxie, James A.
    Mick, Rosemarie
    Vonderheide, Robert H.
    Porter, David L.
    BLOOD, 2014, 124 (21)
  • [4] Prophylaxis of acute graft-versus-host disease by CCR5 blockade combined with cyclosporine A in a murine model
    Jing Yuan
    Han-yun Ren
    Yong-jin Shi
    Wei Liu
    Inflammation Research, 2015, 64 : 137 - 144
  • [5] Prophylaxis of acute graft-versus-host disease by CCR5 blockade combined with cyclosporine A in a murine model
    Yuan, Jing
    Ren, Han-yun
    Shi, Yong-jin
    Liu, Wei
    INFLAMMATION RESEARCH, 2015, 64 (02) : 137 - 144
  • [6] Chemokine Receptor CCR5 Mediates AlloImmune Responses in Graft-versus-Host Disease
    Palmer, Lisa A.
    Sale, George E.
    Balogun, John I.
    Li, Dan
    Jones, Dan
    Molldrem, Jeffrey J.
    Storb, Rainer F.
    Ma, Qing
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (03) : 311 - 319
  • [7] Prevention of Graft-Versus-Host Disease by Inhibition of Lymphocyte Trafficking Using a CCR5 Antagonist
    Reshef, Ran
    Luger, Selina M.
    Loren, Alison W.
    Frey, Noelle V.
    Goldstein, Steven C.
    Hexner, Elizabeth O.
    Stadtmauer, Edward A.
    Smith, Jacqueline
    Mick, Rosemarie
    Heitjan, Daniel F.
    Shetzline, Susan E.
    Danet-Desnoyers, Gwenn-ael H.
    Emerson, Stephen G.
    Hoxie, James A.
    Vonderheide, Robert H.
    Porter, David L.
    BLOOD, 2010, 116 (21) : 295 - 296
  • [8] Expression of CCR5 in graft-versus-host disease (GVHD) of the skin: Immunohistochemical staining of 38 cases
    Morita, Naoko I.
    Matsumura, Yumi
    Morita, Kazumasa
    Miyachi, Yoshiki
    JOURNAL OF DERMATOLOGY, 2007, 34 (04): : 254 - 257
  • [9] Blockade of Chemotaxis in Graft-versus-Host Disease
    Davies, Jeff K.
    Gribben, John G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (17): : 1667 - 1667
  • [10] GRAFT-VERSUS-HOST REACTIONS IN IMMUNOLOGIC DEFICIENCY DISEASE
    DOUGLAS, SD
    FUDENBER.HH
    NEW ENGLAND JOURNAL OF MEDICINE, 1969, 281 (19): : 1077 - &
12345